Celldex Therapeutics, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY4702
◆発行会社(調査会社):MarketLine
◆発行日:2020年2月
◆ページ数:47
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Celldex Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Celldex Therapeutics, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Celldex Therapeutics, Inc (Celldex or ‘the company’) produces and sellscancer-treating biologics and immunotherapy technologies such as vaccines, antibody drug conjugates, protein-based therapeutics and immune system modulators that treats cancer and other crtical diseases. It also develops innovative therapies for patients with unmet medical needs. The company also works with various external parties such as government agencies for advancing its drug candidates. It operates research laboratories in New Jersey, Massachusetts and Connecticut, the US. The company is headquartered in Hampton, New Jersey, the US.

Scope

- Detailed information on Celldex Therapeutics, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Celldex Therapeutics, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Celldex Therapeutics, Inc. including a breakdown and examination of key business segments
- Intelligence on Celldex Therapeutics, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Celldex Therapeutics, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Celldex Therapeutics, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Celldex Therapeutics, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Celldex Therapeutics, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Celldex Therapeutics, Inc.: Company Overview
Celldex Therapeutics, Inc.: Overview and Key Facts
Celldex Therapeutics, Inc.: Overview
Celldex Therapeutics, Inc.: Key Facts
Celldex Therapeutics, Inc.: Key Employees
Celldex Therapeutics, Inc.: Key Employee Biographies
Celldex Therapeutics, Inc.: Major Products and Services
Celldex Therapeutics, Inc.: Company History
Celldex Therapeutics, Inc.: Management Statement
Celldex Therapeutics, Inc.: Locations and Subsidiaries
Celldex Therapeutics, Inc.: Key Competitors
Celldex Therapeutics, Inc.: Company Analysis
Celldex Therapeutics, Inc.: Business Description
Celldex Therapeutics, Inc.: SWOT Analysis
Celldex Therapeutics, Inc.: SWOT Overview
Celldex Therapeutics, Inc.: Strengths
Celldex Therapeutics, Inc.: Weaknesses
Celldex Therapeutics, Inc.: Opportunities
Celldex Therapeutics, Inc.: Threats
Celldex Therapeutics, Inc.: Corporate Financial Deals Activity
Celldex Therapeutics, Inc.: Financial Deals Overview
Celldex Therapeutics, Inc.: Targets and Partners
Celldex Therapeutics, Inc.: Top Deals 2016 – 2020YTD*
Celldex Therapeutics, Inc.: Advisors
Celldex Therapeutics, Inc.: Top Legal Advisors
Celldex Therapeutics, Inc.: Mergers and Acquisitions
Celldex Therapeutics, Inc.: Capital Raising
Celldex Therapeutics, Inc.: Recent Developments
Celldex Therapeutics, Inc.: News and Events Summary
Celldex Therapeutics, Inc.: Business Expansion
Celldex Therapeutics, Inc.: Corporate Governance
Celldex Therapeutics, Inc.: Financial Performance
Celldex Therapeutics, Inc.: Regulatory and Legal Events
Celldex Therapeutics, Inc.: Research & Development
Celldex Therapeutics, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Celldex Therapeutics, Inc.: Key Facts
Table 2: Celldex Therapeutics, Inc.: Key Employees
Table 3: Celldex Therapeutics, Inc.: Company History
Table 4: Celldex Therapeutics, Inc.: Locations and Subsidiaries
Table 5: Celldex Therapeutics, Inc.: Key Competitors
Table 6: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Celldex Therapeutics, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 8: Celldex Therapeutics, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Celldex Therapeutics, Inc.: Targets and Partners
Table 10: Celldex Therapeutics, Inc.: Top Deals 2016 - 2020YTD*
Table 11: Celldex Therapeutics, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Celldex Therapeutics, Inc.: M&A Volume and Value Trend (2016 - YTD*2020)
Table 13: Celldex Therapeutics, Inc.: M&A Activity by Geography (2016 - YTD*2020)
Table 14: Celldex Therapeutics, Inc.: Capital Raising Volume and Value Trend (2016 - YTD*2020)
Table 15: Celldex Therapeutics, Inc.: Capital Raising by Deal Type (2016 - YTD*2020)
Table 16: Celldex Therapeutics, Inc.: News and Events Summary
Table 17: Celldex Therapeutics, Inc.: Business Expansion
Table 18: Celldex Therapeutics, Inc.: Corporate Governance
Table 19: Celldex Therapeutics, Inc.: Financial Performance
Table 20: Celldex Therapeutics, Inc.: Regulatory and Legal Events
Table 21: Celldex Therapeutics, Inc.: Research & Development
Table 22: Celldex Therapeutics, Inc.: Strategy and Operations

★海外企業調査レポート[Celldex Therapeutics, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Oxford University Innovation Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford University Innovation Ltd (Oxford University Innovation), formerly Isis Innovation Ltd a subsidiary of University of Oxford is a technology transfer university that offers academic consulting services and leads to research and education. The university offers university consulting, me …
  • Cyprotex Ltd-医療機器分野:企業M&A・提携分析
    Summary Cyprotex Ltd (Cyprotex), a subsidiary of Evotec AG is a provider of ADME-Tox contract research services. It provides these services to the biotechnology, pharmaceutical, cosmetics/personal care and chemical industries. The company’s core capabilities include high quality mechanistic toxicolo …
  • Pictet & Cie Group SCA:企業の戦略・SWOT・財務情報
    Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report Summary Pictet & Cie Group SCA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Chembio Diagnostic Inc (CEMI):企業の財務・戦略的SWOT分析
    Chembio Diagnostic Inc (CEMI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Siemens AG (SIE):製薬・医療:M&Aディール及び事業提携情報
    Summary Siemens AG (Siemens) is a technology company that offers products and solutions for electrification, automation and digitization. The company offers products, services and solutions for power generation, transmission and distribution; oil and gas production and transportation; medical imagin …
  • Panhandle Oil and Gas Inc (PHX):企業の財務・戦略的SWOT分析
    Panhandle Oil and Gas Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Callitas Therapeutics Inc (LILY):医療機器:M&Aディール及び事業提携情報
    Summary Callitas Therapeutics Inc (Callitas Therapeutics), formerly M Pharmaceutical Inc, is a drug discovery and development company that offers ground-breaking drug treatments and biomedical technologies. The company’s products include weight management products, infertility products and women’s h …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • HollyFrontier Corporation (HFC)-石油・ガス分野:企業M&A・提携分析
    Summary HollyFrontier Corporation (HollyFrontier) is an independent energy company. It carries out crude oil refining and wholesale marketing of refined petroleum products. The company produces and markets high-value light products such as gasoline, diesel, jet fuel, specialty lubricant products, he …
  • Immco Diagnostics Inc-製薬・医療分野:企業M&A・提携分析
    Summary IMMCO Diagnostics Inc (IMMCO), a subsidiary of Trinity Biotech Plc is a biotechnology company that offers autoimmune disease diagnostic solutions. The company offers a wide range of IFAs, EIAs, Line Immunoassays and Western Blots for an extensive variety of autoimmune disorders. It also deve …
  • KBR Inc (KBR):企業の財務・戦略的SWOT分析
    KBR Inc (KBR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • BrainLAB AG:医療機器:M&Aディール及び事業提携情報
    Summary BrainLAB AG (Brainlab) is a medical technology company that develops, manufactures and markets medical technology facilitated by software that helps optimize treatment outcomes. The company provides technological solutions in radiosurgery and numerous surgical fields such as neurosurgery, or …
  • Citizens Electric Corporation:発電所・企業SWOT分析
    Citizens Electric Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務情報
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Astrotech Corporation
    Astrotech Corporation - Strategy, SWOT and Corporate Finance Report Summary Astrotech Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CooperVision Inc:企業の製品パイプライン分析2018
    Summary CooperVision Inc (CooperVision), a subsidiary of The Cooper Companies Inc, designs and manufactures soft contact lenses. It manufactures a wide array of monthly, two-week and daily disposable contact lenses. CooperVision helps overcome various vision challenges such as astigmatism and presby …
  • Argonaut Gold Inc.:企業の戦略・SWOT・財務情報
    Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Argonaut Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Glacier Media Inc. (GVC):企業の財務・戦略的SWOT分析
    Glacier Media Inc. (GVC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Wanbury Ltd (WANBURY):企業の財務・戦略的SWOT分析
    Summary Wanbury Ltd (Wanbury) is a pharmaceutical company that manufactures and sells active pharmaceutical ingredients. The company offers products such as Cpink tablet, rabiplus capsule, cdense tablets, gems, adtrol-plus soft gelatin capsule, folinine softule, cheer capsule and cheer syrup. It inc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆